Li Dean Y insider trades
Li Dean Y has filed 47 Form 4s with the SEC that we hold, for Recursion Pharmaceuticals, INC. (RXRX) (Director) and Merck & Co., Inc. (MRK) (Executive VP & President, MRL). Across all of them we count 0 purchases worth $0 and 9 sales worth $5.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($3.0M). The largest single trade was a sale of 14,702 shares of Merck & Co., Inc. worth $1.8M, dated 2024-02-09. The first filing on our record is dated 2021-07-06 and the latest 2026-10-02.
Recursion Pharmaceuticals, INC. (RXRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-17 | S, sale reported on Form 4 | 5,626 | $112.7K | 2021-12-09 |
| 2021-11-19 | S, sale reported on Form 4 | 13,474 | $272.2K | 2021-12-09 |
| 2021-12-07 | S, sale reported on Form 4 | 1,000 | $21.1K | 2021-12-09 |
| 2021-12-07 | S, sale reported on Form 4 | 14,900 | $304.6K | 2021-12-09 |
| 2024-01-09 | S, sale reported on Form 4 | 962 | $13.5K | 2024-01-11 |
| 2024-01-09 | S, sale reported on Form 4 | 28,038 | $382.7K | 2024-01-11 |
Merck & Co., Inc. (MRK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-02-09 | S, sale reported on Form 4 | 14,702 | $1.8M | 2024-02-12 |
| 2026-02-04 | S, sale reported on Form 4 | 15,087 | $1.8M | 2026-02-06 |
| 2026-02-10 | S, sale reported on Form 4 | 10,235 | $1.2M | 2026-02-10 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1837016) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms